Acute Renal Failure in a Patient with Rivaroxaban-Induced Hypersensitivity Syndrome: A Case Report with a Review of the Literature and of Pharmacovigilance Registries
Direct oral anticoagulants (DOACs) are among the most commonly prescribed medications, and DOAC-associated kidney dysfunction may be a problem that is underrecognized by clinicians. We report on the case of an 82-year-old patient who, two weeks after the prescription of rivaroxaban for atrial fibril...
Main Authors: | Gisela Marcelino, Ould Maouloud Hemett, Eric Descombes |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Case Reports in Nephrology |
Online Access: | http://dx.doi.org/10.1155/2020/6940183 |
Similar Items
-
Oral Postdialysis Cholecalciferol Supplementation in Patients on Maintenance Hemodialysis: A Dose-Response Approach
by: Eric Descombes, et al.
Published: (2014-01-01) -
Allopurinol-induced Severe Hypersensitivity with Acute Renal Failure
by: I-Hung Chen
Published: (2005-05-01) -
International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
by: Jan Beyer-Westendorf, et al.
Published: (2019-04-01) -
Literature Monitoring for Pharmacovigilance
by: A. G. Khudoshin, et al.
Published: (2019-03-01) -
Improvement of Cardiac Vegetations in Antiphospholipid Syndrome with Enoxaparin and Corticosteroids after Rivaroxaban Failure
by: Eric Granowicz, et al.
Published: (2018-01-01)